|
|
Volumn 137, Issue 1, 2018, Pages 88-90
|
|
Effect of basal insulin glargine on first and recurrent episodes of heart failure hospitalization: The ORIGIN trial (outcome reduction with initial glargine intervention)
a
|
|
Author keywords
Heart failure; Hospitalization; Insulin glargine
|
|
Indexed keywords
INSULIN GLARGINE;
ANTIDIABETIC AGENT;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL OUTCOME;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG USE;
FOLLOW UP;
HEALTH CARE QUALITY;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
INTENTION TO TREAT ANALYSIS;
MORTALITY RISK;
NEW YORK HEART ASSOCIATION CLASS;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECURRENT DISEASE;
SAMPLE SIZE;
STUDY DESIGN;
CLINICAL TRIAL;
FEMALE;
INCIDENCE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
TIME FACTOR;
TREATMENT OUTCOME;
DIABETES MELLITUS;
FEMALE;
HEART FAILURE;
HOSPITALIZATION;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCIDENCE;
INSULIN GLARGINE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RECURRENCE;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 85047464547
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.117.030924 Document Type: Article |
|
Times cited : (33)
|
|
References (5)
|
